<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>prognostic biomarker &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/prognostic-biomarker/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 23 Jan 2026 22:39:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>prognostic biomarker &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Can Red Blood Cell Width Predict T-Cell Lymphoma Outcomes?</title>
		<link>https://bioengineer.org/can-red-blood-cell-width-predict-t-cell-lymphoma-outcomes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 22:39:04 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Hematologic Malignancy]]></category>
		<category><![CDATA[Hematological malignancy outcomes]]></category>
		<category><![CDATA[inflammation biomarkers]]></category>
		<category><![CDATA[İşte 5 uygun etiket]]></category>
		<category><![CDATA[Makalenin içeriğine ve odak noktalarına göre uygun 5 etiket: **Peripheral T-cell lymphoma]]></category>
		<category><![CDATA[Patient Outcomes** **Açıklama:** 1. **Red Blood Cell Distribution Width:** Makalenin temel araştırma konusu olan RDW'yi doğrudan belirtir. 2. **Per]]></category>
		<category><![CDATA[Peripheral T-Cell Lymphoma]]></category>
		<category><![CDATA[Personalized cancer therapy** * **Peripheral T-cell lymphoma:** Makalenin ana konusu olan spesifik lenfoma tipi. * **RDW prognostic marker:** Çalışmanın temel bulgusu]]></category>
		<category><![CDATA[prognostic biomarker]]></category>
		<category><![CDATA[RDW prognostic marker]]></category>
		<category><![CDATA[RDW'nin bir]]></category>
		<category><![CDATA[virgülle ayrılmış halde: **Red Blood Cell Distribution Width]]></category>
		<guid isPermaLink="false">https://bioengineer.org/can-red-blood-cell-width-predict-t-cell-lymphoma-outcomes/</guid>

					<description><![CDATA[In recent months, significant attention has been directed toward the role of red blood cell distribution width (RDW) as a potential prognostic factor in various medical conditions. Among the myriad of studies conducted, a fresh investigation spearheaded by Lan, Zhao, and Sun has shone a light on peripheral T-cell lymphoma (PTCL), a type of cancer [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320033</post-id>	</item>
		<item>
		<title>PLXNA3 Gene: Impact on Breast Cancer Prognosis</title>
		<link>https://bioengineer.org/plxna3-gene-impact-on-breast-cancer-prognosis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 07 Jan 2026 23:07:08 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[İçeriğin odak noktalarına (PLXNA3 geni]]></category>
		<category><![CDATA[immün özellikler]]></category>
		<category><![CDATA[Immune cell infiltration]]></category>
		<category><![CDATA[meme kanseri prognozu]]></category>
		<category><![CDATA[moleküler mekanizma) göre uygun 5 etiket: **PLXNA3 breast cancer]]></category>
		<category><![CDATA[prognostic biomarker]]></category>
		<category><![CDATA[Semaphorin signaling** * **PLXNA3 breast cancer:** Ana konu olan gen ve kanser t]]></category>
		<category><![CDATA[tumor-immune microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/plxna3-gene-impact-on-breast-cancer-prognosis/</guid>

					<description><![CDATA[The world of cancer research is continuously evolving, with scientists constantly searching for new biomarkers and genetic indicators that can influence prognosis and treatment response. A recent study has emerged from this ongoing quest, shedding light on the PLXNA3 gene in relation to breast cancer. This fundamental research provides a comprehensive analysis that holds the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">314634</post-id>	</item>
		<item>
		<title>New Study Identifies Promising Prognostic Marker for Advanced Lung Adenocarcinoma</title>
		<link>https://bioengineer.org/new-study-identifies-promising-prognostic-marker-for-advanced-lung-adenocarcinoma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 05 Aug 2025 18:32:18 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[lipid metabolism]]></category>
		<category><![CDATA[lung adenocarcinoma progression]]></category>
		<category><![CDATA[perilipin 2]]></category>
		<category><![CDATA[prognostic biomarker]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-study-identifies-promising-prognostic-marker-for-advanced-lung-adenocarcinoma/</guid>

					<description><![CDATA[Philadelphia, August 5, 2025 – A groundbreaking study published in The American Journal of Pathology unveils the pivotal role of perilipin 2, a lipid droplet-associated protein, in driving the progression of lung adenocarcinoma, the most prevalent subtype of lung cancer worldwide. Researchers have identified that perilipin 2 profoundly impacts tumor aggressiveness by modulating lipid metabolism [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">253496</post-id>	</item>
		<item>
		<title>Prognostic value of troponin I in COVID-19 patients</title>
		<link>https://bioengineer.org/prognostic-value-of-troponin-i-in-covid-19-patients/</link>
					<comments>https://bioengineer.org/prognostic-value-of-troponin-i-in-covid-19-patients/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 28 May 2021 13:47:44 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[mortality predictor]]></category>
		<category><![CDATA[myocardial injury]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Pharmaceutical Sciences]]></category>
		<category><![CDATA[Pharmaceutical/Combinatorial Chemistry]]></category>
		<category><![CDATA[prognostic biomarker]]></category>
		<category><![CDATA[troponin I]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/prognostic-value-of-troponin-i-in-covid-19-patients/</guid>

					<description><![CDATA[This article by Dr. Alaa A. Ghaleb and colleagues is published in The Open Cardiovascular Medicine Journal, 2021 Corona Virus Disease (COVID -19) patients primarily appear with respiratory issues and viral pneumonia. The patients may also present cardiovascular issues includes early signs of acute myocardial injury. The researchers from Sohag University, Egypt, found that cardiac [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/prognostic-value-of-troponin-i-in-covid-19-patients/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">170415</post-id>	</item>
	</channel>
</rss>
